Noblegen commercializes a suite of fermentation-derived food ingredients made from the single-celled micro-organism Euglena gracilis, including a protein-rich euglena flour, high-purity beta glucan isolates, protein concentrates/isolates, wet animal-analog materials, and functional oils. The company uses a proprietary facilitated expression technique that does not involve genetic engineering and has secured self-determined GRAS status for its first protein-rich ingredient. Noblegen emphasizes euglena's rapid growth (replicating every 12–24 hours) and high feed conversion efficiency (70–80%) as drivers of cost and sustainability advantages, noting a minimal water and land footprint and no process waste stream. Its product roadmap includes protein concentrates and isolates launching in 2022, followed by wet meat, egg, and dairy analogs with full GRAS clearances for wet products in 2023–2024. The company plans to ramp in‑house production initially in Peterborough, Ontario, then scale via a global tolling network of fermentation facilities, while expanding R&D and hiring new talent. Founded in 2013 by Adam Noble (originally Noble Tech), Noblegen is positioning its ingredients as replacements for additives like methylcellulose and titanium dioxide and as more sustainable alternatives to palm oil. Noblegen is an advanced ingredients company that makes protein, carbohydrate and oil ingredients using the microorganism Euglena gracilis. Founded in 2013 by CEO and Chairman Adam Noble and based in Peterborough, Ontario, the company employs over 50 people. It secured CAD$25m in Series B financing, bringing total funding to date to CAD$42.5m. The company intends to use the funds for commercialization of its products, to continue research and development, and to grow its production and refining capacity. Noblegen planned to launch its ingredients in the U.S. in 2019. Its product set targets ingredient markets for protein, carbohydrates and oils derived from microalgae. Noblegen is a Peterborough-based biotech company that develops microorganism products by sustainably growing algae. It has developed a production process to grow algae for bioproducts including plant-based proteins and oils. Those bioproducts can be used across food and beverage, supplements, cosmetics, and water purification, and as substitutes for non-renewable materials. Founder and CEO Adam Noble said the company aims to get its sustainable products into the hands of the largest global actors while creating local employment. Noblegen plans to initially target the nutritional supplements and animal nutrition markets to increase access to environmentally responsible products. The company received government support to expand marketing and accelerate global sales.

Total raised

$19M

Funding rounds

3

Latest round

Series B

Latest activity

May 2019